A phase IV, open-label, randomized, multicenter trial assessing the efficacy of a treatment maintenance phase with unboosted vs boosted Reyataz after an induction phase with Reytaz and Ritonavir in treatment naive HIV patients

• Conditions: HIV treatment; MedDRA version: 6.1Level: HLTClassification code 10038997

• Registration Number: EUCTR2005-000865-21-IT
• Lead Sponsor: BRISTOL-M.SQUIBB

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01-30
• Last Update Posted: 24 April 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified